Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2018-02-01
2022-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epi-on CuRV and Epi-off aCXL Protocols in the Management of Keratoconus
NCT07173907
Treatment of Keratoconus With Advanced CXL-II
NCT02514200
Customized Crosslinking: Safety and Efficacy in an Epithelium-off Accelerated-pulsated Protocol for Thin Keratoconus
NCT06159881
Corneal Crosslinking Treatment Study
NCT04427956
Epi Off Versus Epi on Corneal Collagen Cross-linking in Keratoconus Patients
NCT03598634
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Customized, transepithelial cross-linking
All study patients will be treated according to the customized remodeled vision protocol
Cross-linking
Oxygen-boosted, epithelium-on, customized cross-linking. Highest UV-A application is focused on the apex of the cone. The cone area receives a moderate amount of UV-A, while healthy cornea is spared.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cross-linking
Oxygen-boosted, epithelium-on, customized cross-linking. Highest UV-A application is focused on the apex of the cone. The cone area receives a moderate amount of UV-A, while healthy cornea is spared.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* maximum corneal curvature (Kmax) ≥47.00 D,
* localized steepening on topographic maps,
* localized elevation in the anterior and posterior corneal surfaces.
Exclusion Criteria
* Thinnest corneal pachymetry \< 380 μm
* History of corneal surgery, including previous cross-linking
* Corneal scarring
* Aphakia
* Pseudophakia
* Any visually significant ocular condition
12 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ophthalmica Eye Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miltos Balidis, PhD
Role: PRINCIPAL_INVESTIGATOR
Ophthalmica Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ophthalmica Eye Institute
Thessaloniki, Kalamaria, Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Seiler TG, Fischinger I, Koller T, Zapp D, Frueh BE, Seiler T. Customized Corneal Cross-linking: One-Year Results. Am J Ophthalmol. 2016 Jun;166:14-21. doi: 10.1016/j.ajo.2016.02.029. Epub 2016 Mar 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OphthalmicaEI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.